Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Immunotech Laboratories Inc    IMMB

IMMUNOTECH LABORATORIES INC (IMMB)
My previous session
Most popular
  Report  
Delayed Quote. Delayed  - 09/17 06:10:56 pm
1.0E-6 USD   --.--%
2009IMMUNOTECH LABO : Immunotech Completes Merger Acquisition
PR
 SummaryQuotesChartsNewsCompany 
OFFRE
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
11/08/2017 02/08/2018 09/12/2018 09/17/2018 Date
0.0001(c) 1.0E-6(c) 0(c) 1.0E-6(c) Last
0 120 000 0 6 34 900 Volume
-99.00% -100.00% Change
More quotes
Company
Immunotech Laboratories, Inc. is a drug development company.It engages in the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.The company was founded on April 11, 2000 and is headquartered in Glendale, CA. 
More about the company
Latest news on IMMUNOTECH LABORATORIES IN
02/28IMMUNOTECH LABORATORIES : Enters Negotiations to Engage a Quality Person (QP) fo..
AQ
01/04IMMUNOTECH LABORATORIES : Receives Invitation to the 2018 Asia-Pacific Precision..
AQ
2017IMMUNOTECH LABORATORIES : ECPO Year End Update and Announces Appointment of Dr. ..
AQ
2009IMMUNOTECH LABORAT : Immunotech Completes Merger Acquisition
PR
More news
Sector news : Bio Therapeutic Drugs
09/19NOVARTIS : U.K. Pulls Brakes on Novartis' CAR-T Drug in First European Setback -..
DJ
09/19NOVARTIS : U.K. Pulls Brakes on Novartis' CAR-T Drug for Some Patients Despite D..
DJ
09/19GILEAD SCIENCES : UK rejects adult Novartis CAR-T therapy, after 'yes' in kids
RE
09/18REGENERON PHARMACEUTICALS : Sanofi pledges to keep up its restructuring efforts
RE
09/14Allogene, Which Announced Pfizer Agreement in April, Discloses IPO Plans
DJ
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
2016HERBALIFE : Never Again 
Chart IMMUNOTECH LABORATORIES INC
Duration : Period :
Immunotech Laboratories Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Harry H. Zhabilov Chairman, President & Chief Executive Officer
Valentin Ivanov Dimitrov Director
Billy Ray Head-Business & Development
Adam Samuel Tracy Legal Counsel
Sector and Competitors
1st jan.Capitalization (M$)
IMMUNOTECH LABORATORIES INC-99.00%0
GILEAD SCIENCES4.45%97 005
VERTEX PHARMACEUTICALS17.84%46 134
REGENERON PHARMACEUTICALS2.06%41 105
NEUROCRINE BIOSCIENCES, INC.51.32%10 877
GENMAB1.90%10 184